Samil Pharm - Asset Resilience Ratio

Latest as of September 2022: 0.00%

Samil Pharm (000520) has an Asset Resilience Ratio of 0.00% as of September 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000520 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩5.80 Million

≈ $3.93K USD Cash + Short-term Investments

Total Assets

₩288.86 Billion

≈ $195.76 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2021)

This chart shows how Samil Pharm's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Samil Pharm assets under control.

Liquid Assets Composition Over Time

This chart breaks down Samil Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Samil Pharm to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩5.80 Million	0.0%
Total Liquid Assets	₩5.80 Million	0.00%

Asset Resilience Insights

Limited Liquidity: Samil Pharm maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Samil Pharm Industry Peers by Asset Resilience Ratio

Compare Samil Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Samil Pharm (2011–2021)

The table below shows the annual Asset Resilience Ratio data for Samil Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	4.98%	₩11.27 Billion ≈ $7.64 Million	₩226.40 Billion ≈ $153.43 Million	+4.35pp
2020-12-31	0.63%	₩1.20 Billion ≈ $813.22K	₩191.66 Billion ≈ $129.89 Million	-6.46pp
2019-12-31	7.09%	₩13.03 Billion ≈ $8.83 Million	₩183.87 Billion ≈ $124.61 Million	+1.68pp
2018-12-31	5.41%	₩8.00 Billion ≈ $5.42 Million	₩147.95 Billion ≈ $100.26 Million	+3.43pp
2016-12-31	1.98%	₩2.00 Billion ≈ $1.36 Million	₩101.00 Billion ≈ $68.44 Million	-0.03pp
2015-12-31	2.01%	₩2.00 Billion ≈ $1.36 Million	₩99.31 Billion ≈ $67.30 Million	-7.22pp
2014-12-31	9.23%	₩10.00 Billion ≈ $6.78 Million	₩108.29 Billion ≈ $73.39 Million	+9.18pp
2012-12-31	0.05%	₩55.00 Million ≈ $37.27K	₩111.00 Billion ≈ $75.22 Million	-0.32pp
2011-12-31	0.37%	₩443.46 Million ≈ $300.53K	₩121.20 Billion ≈ $82.14 Million	--

pp = percentage points

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$100.85 Million

₩148.82 Billion KRW

Market Cap Rank

#19238 Global

#944 in Korea

Share Price

₩7010.00

Change (1 day)

-0.57%

52-Week Range

₩5830.00 - ₩12310.00

All Time High

₩23603.13